{"disease":{"id":"recurrent-calcium-renal-calculi","name":"Recurrent Calcium Renal Calculi","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":1,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"allopurinol","indication_name":"Recurrent Calcium Renal Calculi","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aloprim","generic_name":"ALLOPURINOL","company_name":"Casper Pharma Llc","drug_phase":"marketed","molecular_target":"Xanthine dehydrogenase/oxidase","drug_class":"Xanthine Oxidase Inhibitor [EPC]","quality_score":70,"revenue":null,"mechanism":"Aloprim works by inhibiting the enzyme xanthine oxidase, which is responsible for producing uric acid in the body."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}